0.1104
price down icon23.23%   -0.0334
 
loading

Aptose Biosciences Inc Stock (APTO) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
19.52%
9.76
12.13 11.68 14.45 14.10
Nonoperating Income/Loss
30.23%
0.12
0.172 0.234 0.323 0.42
Income/Loss From Continuing Operations Before Tax
104.18%
0.50
-11.96 -11.45 -14.13 -13.68
Income/Loss From Continuing Operations After Tax
104.18%
0.50
-11.96 -11.45 -14.13 -13.68
Net Income/Loss
19.36%
-9.64
-11.96 -11.45 -14.13 -13.68
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,508%
13.13
0.364 6.495 6.234 92.56
Diluted Average Shares
3,508%
13.13
0.364 6.495 6.234 92.56
Basic Earnings Per Share
53.50%
-0.73
-1.57 -1.76 -2.27 -2.25
Diluted Earnings Per Share
53.50%
-0.73
-1.57 -1.76 -2.27 -2.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$74.40
price up icon 0.53%
$22.96
price up icon 2.04%
$33.69
price down icon 0.33%
$357.50
price down icon 0.20%
$110.97
price down icon 5.14%
biotechnology ONC
$259.70
price up icon 0.47%
Cap:     |  Volume (24h):